Introduction
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease characterized by the selective loss of motor neurons across the motor cortex, brainstem, and spinal cord, dramatically reducing life expectancy. Understanding the historical milestones of ALS provides essential context for modern neurodegenerative research and clinical classification. From initial clinical observations in 19th-century Europe to public recognition in the United States, the evolving nomenclature reflects our deepening knowledge of motor neuron disease.
Pioneering Discoveries in Neurobiology
The clinical and pathological identity of ALS was first established in 1869 by Jean-Martin Charcot, the renowned French neurologist. Charcot recognized that patients presenting with progressive muscle atrophy and spasticity suffered from dual pathology involving both upper motor neurons (UMNs) and lower motor neurons (LMNs). In France, the disease gained the designation Sclérose Latérale Amyotrophique (SLA).
In the United Kingdom, Sir William Gowers significantly expanded the understanding of motor system degeneration, reinforcing the unifying concept of motor neuron disease (MND).
Nomenclature and Public Awareness
Public awareness of ALS shifted dramatically in 1939 when famous American baseball player Lou Gehrig was diagnosed with the condition, leading to the common usage of the term "Lou Gehrig's disease" in the United States.
| Historical Figure / Event | Year | Key Contribution / Terminology |
| Jean-Martin Charcot | 1869 | First scientific description; defined dual UMN & LMN pathology (SLA) |
| Sir William Gowers | Late 19th C. | Advanced Motor Neuron Disease (MND) framework in the UK |
| Lou Gehrig | 1939 | Popularized "Lou Gehrig's Disease" term in the United States |
Modern Conceptualization
Today, ALS is recognized as the most frequent adult-onset motor neuron disorder. Charcot’s original insight—that combined upper and lower motor neuron degeneration drives disease manifestations—remains the fundamental diagnostic foundation.
Key Takeaways
ALS was first described by Jean-Martin Charcot in 1869.
The disease involves concurrent loss of upper motor neurons (cortex) and lower motor neurons (brainstem/spinal cord).
Regional terminology varies, including Sclérose Latérale Amyotrophique in France and MND in the UK.